To our knowledge, no prior studies have been undertaken to determine PD-L1/PD-L2 in blood and to correlate their presence with the response to treatment for metastatic melanoma, although comparable studies have been conducted regarding other tumours [34,35,36]. This evidence concerns the gene PDCD1LG2 and neoplasm.